Climate Crisis Has ‘Opened the Gates to Hell’ UN Chief Tells Summit

 UN Secretary-General Antonio Guterres attends the UN Climate Ambition Summit on the sidelines of the 78th United Nations General Assembly at UN headquarters in New York City on September 20, 2023. (AFP)
UN Secretary-General Antonio Guterres attends the UN Climate Ambition Summit on the sidelines of the 78th United Nations General Assembly at UN headquarters in New York City on September 20, 2023. (AFP)
TT

Climate Crisis Has ‘Opened the Gates to Hell’ UN Chief Tells Summit

 UN Secretary-General Antonio Guterres attends the UN Climate Ambition Summit on the sidelines of the 78th United Nations General Assembly at UN headquarters in New York City on September 20, 2023. (AFP)
UN Secretary-General Antonio Guterres attends the UN Climate Ambition Summit on the sidelines of the 78th United Nations General Assembly at UN headquarters in New York City on September 20, 2023. (AFP)

UN Secretary-General Antonio Guterres on Wednesday told world leaders humanity's addiction to fossil fuels had "opened the gates to hell" as he kicked off a climate meeting where leading polluters China and the United States were conspicuously absent.

Despite increasing extreme weather events and record-shattering global temperatures, greenhouse gas emissions continue to rise and oil and gas companies reap handsome profits.

Guterres has thus billed the "Climate Ambition Summit" as a "no nonsense" forum where leaders or cabinet ministers will announce specific actions that deliver on their commitments under the Paris Agreement.

In his opening speech, he evoked 2023's "horrendous heat" and "historic fires," but stressed: "The future is not fixed: It is for leaders like you to write.

"We can still limit the rise in global temperature to 1.5 degrees. We can still build a world of clear air, green jobs and affordable clean power for all," he said, referring to the target seen as needed to avoid long-term climate catastrophe.

The bar for the podium was set high, with the UN chief making clear that only leaders who had made concrete plans to achieve net-zero greenhouse emissions would be allowed to speak.

After receiving more than 100 applications to take part, the UN finally released a list on Tuesday night of 41 speakers which did not include China, the United States, the United Kingdom, Japan or India.

Several major leaders didn't bother making the trip to New York for this year's UN General Assembly, including President Xi Jinping of China and Prime Minister Rishi Sunak from the United Kingdom, who said he was too busy.

US President Joe Biden, who addressed the General Assembly on Tuesday, sent his climate envoy John Kerry to the meeting -- although Kerry won't be permitted to speak in the segment reserved for "movers and doers."

"There's no doubt that the absence of so many leaders from the world's biggest economies and emitters will clearly have an impact on the outcomes of the summit," Alden Meyer of climate think tank E3G said.

He blamed competing issues -- from the Ukraine conflict to US-China tensions and rising economic uncertainty -- but also the lobbying power of the fossil fuel industry.

Catherine Abreu, executive director of nonprofit Destination Zero, said it was "perhaps a good-news story that we see Biden not being given a speaking slot at the summit" because the United States is continuing to expand fossil fuel projects even as it makes historic investments in renewables.

"I think about this as being a correction from past summits, where leaders have been given the opportunity to take credit for climate leadership on the global stage, while they continue to pursue plans to develop fossil fuels, and continue driving the climate crisis back at home," she added.

While the United States won't take the rostrum, California will be represented by Governor Gavin Newsom. From Britain, London Mayor Sadiq Khan will also attend.

Broken promises

The event is the biggest climate summit in New York since 2019, when Greta Thunberg stunned the world with her "How Dare You" speech before the UN.

Anger is building among climate activists, particularly younger people, who turned out in thousands last weekend for the "March to End Fossil Fuels" in New York.

Observers are eager however to see what Canadian Prime Minister Justin Trudeau and European Union President Ursula von der Leyen say both on their own goals and on financing commitments for the developing world.

Advanced economies vowed in 2009 to channel $100 billion to less developed countries by the year 2020 -- a promise that was broken -- even as much of the funding that was mobilized came in the form of loans.

Meanwhile, a "loss and damage" fund aimed at providing financial assistance to nations most vulnerable and impacted by the effects of climate change has still not been operationalized.

There are some bright spots, including the announcement that Colombia and Panama are joining a grouping called the Powering Past Coal Alliance -- particularly notable as Colombia is the world's sixth biggest coal exporter.



Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
TT

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)

The anti-obesity drug Ozempic could slow down ageing and has “far-reaching benefits” beyond what was imagined, researchers have suggested.

Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without diabetes, The Independent reported.

Responding to research published in JACC, the flagship journal of the American College of Cardiology, Professor Harlan M Krumholz from the Yale School of Medicine, said: “Semaglutide, perhaps by improving cardiometabolic health, has far-reaching benefits beyond what we initially imagined.”

He added: “These ground-breaking medications are poised to revolutionise cardiovascular care and could dramatically enhance cardiovascular health.”

Multiple reports also quoted Professor Krumholz saying: “Is it a fountain of youth?”

He said: “I would say if you’re improving someone’s cardiometabolic health substantially, then you are putting them in a position to live longer and better.

“It’s not just avoiding heart attacks. These are health promoters. It wouldn’t surprise me that improving people’s health this way actually slows down the ageing process.”

The studies, presented at the European Society of Cardiology Conference 2024 in London, were produced from the Select trial which studied 17,604 people aged 45 or older who were overweight or obese and had established cardiovascular disease but not diabetes.

They received 2.4 mg of semaglutide or a placebo and were tracked for more than three years.

A total of 833 participants died during the study with 5 percent of the deaths were related to cardiovascular causes and 42 per cent from others.

Infection was the most common cause death beyond cardiovascular, but it occurred at a lower rate in the semaglutide group than the placebo group.

People using the weight-loss drug were just as likely to catch Covid-19, but they were less likely to die from it – 2.6 percent dying among those on semaglutide versus 3.1 per cent on the placebo.

Researchers found women experienced fewer major adverse cardiovascular events, but semaglutide “consistently reduced the risk” of adverse cardiovascular outcomes regardless of sex.

Dr Benjamin Scirica, lead author of one of the studies and a professor of cardiovascular medicine at Harvard Medical School, said: “The robust reduction in non-cardiovascular death, and particularly infections deaths, was surprising and perhaps only detectable because of the Covid-19-related surge in non-cardiovascular deaths.

“These findings reinforce that overweight and obesity increases the risk of death due to many etiologies, which can be modified with potent incretin-based therapies like semaglutide.”

Dr Jeremy Samuel Faust, an emergency medicine physician at Brigham and Women’s Hospital, praised the researchers for adapting the study to look at Covid-19 when the pandemic started.

He said the findings that the weight-loss drug to reduce Covid-19 mortality rates were “akin to a vaccine against the indirect effects of a pathogen.”